Platinum‐resistant (PR) ovarian clear cell carcinoma (OCCC) is highly resistant to chemotherapy and has a poor prognosis. Both in‐vitro and clinical studies have suggested that gemcitabine (GEM) is particularly effective… Click to show full abstract
Platinum‐resistant (PR) ovarian clear cell carcinoma (OCCC) is highly resistant to chemotherapy and has a poor prognosis. Both in‐vitro and clinical studies have suggested that gemcitabine (GEM) is particularly effective against OCCC. Moreover, a combination with bevacizumab (Bev) is expected to enhance the efficacy of chemotherapy.
Keywords:
platinum resistant;
resistant ovarian;
ovarian clear;
cell carcinoma;
clear cell
Journal Title: Cancer
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!